Kazuyoshi Ogasawara

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata et al. · Psychiatry and Clinical Neurosciences · 2019 · 46 citations · Full text

Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

Kayo Ichihashi, Hikaru Hori, Naomi Hasegawa et al. · Neuropsychopharmacology Reports · 2020 · 43 citations · Full text

Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study

Ryuji Furihata, Rei Otsuki, Naomi Hasegawa et al. · Sleep Medicine · 2021 · 28 citations

Psychiatry, Psychotropic Medication, Psychopharmacology +8

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

Hikaru Hori, Norio Yasui‐Furukori, Naomi Hasegawa et al. · Frontiers in Psychiatry · 2022 · 23 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +16

[Review of the new treatment guideline for major depressive disorder by the Japanese Society of Mood Disorders].

Kazuyoshi Ogasawara, Norio Ozaki · PubMed · 2012 · 20 citations

Japanese Society, Psychiatric Disorders, Electroconvulsive Therapy +17